Literature DB >> 34191653

Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain.

Brooke Porter, Barbara St Marie, Gary Milavetz, Keela Herr.   

Abstract

Legalization of cannabidiol (CBD) products has ignited interest in clinical practice and research. One desired indication includes possible pain-relieving effects of CBD. The purposes of the current article are to (1) clarify terminology relevant to cannabinoids; (2) explain and understand the pharmacotherapeutics of CBD; (3) examine research of the current use of CBD by older adults for treating pain; (4) discuss safety considerations with using CBD products; and (5) provide best practice recommendations for clinicians as they advise their older adult patients. A review of the literature demonstrated mixed results on the efficacy of CBD in relieving pain in older adults. There is inconsistency in the labeling of over-the-counter CBD products that can result in safety issues and will require more federal quality control. Likewise, gaps in knowledge regarding safety and efficacy of CBD use in older adults are vast and require further research. [Journal of Gerontological Nursing, 47(7), 6-15.].

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34191653      PMCID: PMC8344100          DOI: 10.3928/00989134-20210610-02

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.436


  62 in total

1.  Medical Cannabis Use: Exploring the Perceptions and Experiences of Older Adults with Chronic Conditions.

Authors:  Lydia Manning; Lauren Bouchard
Journal:  Clin Gerontol       Date:  2020-11-29       Impact factor: 2.619

2.  An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.

Authors:  Jeremy R Johnson; Dominique Lossignol; Mary Burnell-Nugent; Marie T Fallon
Journal:  J Pain Symptom Manage       Date:  2012-11-08       Impact factor: 3.612

3.  Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.

Authors:  Tibor M Brunt; Marianne van Genugten; Kathrin Höner-Snoeken; Marco J van de Velde; Raymond J M Niesink
Journal:  J Clin Psychopharmacol       Date:  2014-06       Impact factor: 3.153

Review 4.  Use of cannabidiol (CBD) for the treatment of chronic pain.

Authors:  Ivan Urits; Kyle Gress; Karina Charipova; Kelly Habib; David Lee; Christopher Lee; Jai Won Jung; Hisham Kassem; Elyse Cornett; Antonella Paladini; Giustino Varrassi; Alan D Kaye; Omar Viswanath
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-07-02

5.  Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.

Authors:  Sara J Abdallah; Benjamin M Smith; Mark A Ware; Michelle Moore; Pei Zhi Li; Jean Bourbeau; Dennis Jensen
Journal:  Ann Am Thorac Soc       Date:  2018-10

6.  Chronic administration of cannabidiol to healthy volunteers and epileptic patients.

Authors:  J M Cunha; E A Carlini; A E Pereira; O L Ramos; C Pimentel; R Gagliardi; W L Sanvito; N Lander; R Mechoulam
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

7.  Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois.

Authors:  James Alton Croker; Julie L Bobitt; Kanika Arora; Brian Kaskie
Journal:  Clin Gerontol       Date:  2020-08-26       Impact factor: 2.619

8.  Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry.

Authors:  Michael A Ueberall; Ute Essner; Gerhard Hh Mueller-Schwefe
Journal:  J Pain Res       Date:  2019-05-20       Impact factor: 3.133

9.  An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.

Authors:  Phillip D Good; Ristan M Greer; Georgina E Huggett; Janet R Hardy
Journal:  J Palliat Med       Date:  2019-12-03       Impact factor: 2.947

10.  Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Edward Chesney; Dominic Oliver; Alastair Green; Simina Sovi; Jack Wilson; Amir Englund; Tom P Freeman; Philip McGuire
Journal:  Neuropsychopharmacology       Date:  2020-04-08       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.